|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kato M and Asaka M: Recent knowledge of
the relationship between Helicobacter pylori and gastric cancer and
recent progress of gastroendoscopic diagnosis and treatment for
gastric cancer. Jpn J Clin Oncol. 40:828–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li L, Ying XJ, Sun TT, Yi K, Tian HL, Sun
R, Tian JH and Yang KH: Overview of methodological quality of
systematic reviews about gastric cancer risk and protective
factors. Asian Pac J Cancer Prev. 13:2069–2079. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moon YW, Jeung HC, Rha SY, Yoo NC, Roh JK,
Noh SH, Kim BS and Chung HC: Changing patterns of prognosticators
during 15-year follow-up of advanced gastric cancer after radical
gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at
a single korean institute. Ann Surg Oncol. 14:2730–2737. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marano L, Polom K, Patriti A, Roviello G,
Falco G, Stracqualursi A, De Luca R, Petrioli R, Martinotti M,
Generali D, et al: Surgical management of advanced gastric cancer:
An evolving issue. Eur J Surg Oncol. 42:18–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Markar SR, Karthikesalingam A, Jackson D
and Hanna GB: Long-term survival after gastrectomy for cancer in
randomized, controlled oncological trials: Comparison between West
and East. Ann Surg Oncol. 20:2328–2338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu J, Wang R, Chen J, Wu J, Dang Z, Zhang
Q and Li B: miR-340 inhibits proliferation and induces apoptosis in
gastric cancer cell line SGC-7901, Possibly via the AKT Pathway.
Med Sci Monit. 23:71–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
14
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garzon R and Marcucci G: Potential of
microRNAs for cancer diagnostics, prognostication and therapy. Curr
Opin Oncol. 24:655–659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu D, Niu X, Pan H, Zhou Y, Zhang Z, Qu P
and Zhou J: Tumor-suppressing effects of microRNA-429 in human
renal cell carcinoma via the downregulation of Sp1. Oncol Lett.
12:2906–2911. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Almeida MI, Nicoloso MS, Zeng L, Ivan C,
Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142:886–896.e9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Wu C, Yang Q, Ding M, Zhong J,
Zhang CY, Ge J, Wang J and Zhang C: miR-28-5p acts as a tumor
suppressor in renal cell carcinoma for multiple antitumor effects
by targeting RAP1B. Oncotarget. 7:73888–73902. 2016.PubMed/NCBI
|
|
20
|
Schneider C, Setty M, Holmes AB, Maute RL,
Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R and Basso K:
MicroRNA 28 controls cell proliferation and is down-regulated in
B-cell lymphomas. Proc Natl Acad Sci USA. 111:pp. 8185–8190. 2014;
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fei G, Ebert MP, Mawrin C, Leodolter A,
Schmidt N, Dietzmann K and Malfertheiner P: Reduced PTEN expression
in gastric cancer and in the gastric mucosa of gastric cancer
relatives. Eur J Gastroenterol Hepatol. 14:297–303. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng HC, Li YL, Sun JM, Yang XF, Li XH,
Jiang WG, Zhang YC and Xin Y: Growth, invasion, metastasis,
differentiation, angiogenesis and apoptosis of gastric cancer
regulated by expression of PTEN encoding products. World J
Gastroenterol. 9:1662–1666. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu WT, Yang Z and Lu NH: Roles of PTEN
(phosphatase and tensin homolog) in gastric cancer development and
progression. Asian Pac J Cancer Prev. 15:17–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jing X, Cheng W, Wang S, Li P and He L:
Resveratrol induces cell cycle arrest in human gastric cancer
MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway.
Oncol Rep. 35:472–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang SQ, Wang C, Chang LM, Zhou KR, Wang
JW, Ke Y, Yang DX, Shi HG, Wang R, Shi XL, et al: Geridonin and
paclitaxel act synergistically to inhibit the proliferation of
gastric cancer cells through ROS-mediated regulation of the
PTEN/PI3K/Akt pathway. Oncotarget. 7:72990–73002. 2016.PubMed/NCBI
|
|
27
|
Adams BD, Kasinski AL and Slack FJ:
Aberrant regulation and function of microRNAs in cancer. Curr Biol.
24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mirnezami AH, Pickard K, Zhang L, Primrose
JN and Packham G: MicroRNAs: Key players in carcinogenesis and
novel therapeutic targets. Eur J Surg Oncol. 35:339–347. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou SL, Hu ZQ, Zhou ZJ, Dai Z, Wang Z,
Cao Y, Fan J, Huang XW and Zhou J: miR-28-5p-IL-34-macrophage
feedback loop modulates hepatocellular carcinoma metastasis.
Hepatology. 63:1560–1575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu J, Jiang N, Shi H, Zhao S, Yao S and
Shen H: (Corrigendum) miR-28-5p promotes the development and
progression of ovarian cancer through inhibition of N4BP1. Int J
Oncol. 50:22362017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi X and Teng F: Down-regulated miR-28-5p
in human hepatocellular carcinoma correlated with tumor
proliferation and migration by targeting insulin-like growth
factor-1 (IGF-1). Mol Cell Biochem. 408:283–293. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maehama T and Dixon JE: The tumor
suppressor, PTEN/MMAC1, dephosphorylates the lipid second
messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem.
273:13375–13378. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanaka M, Koul D, Davies MA, Liebert M,
Steck PA and Grossman HB: MMAC1/PTEN inhibits cell growth and
induces chemosensitivity to doxorubicin in human bladder cancer
cells. Oncogene. 19:5406–5412. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y,
Wakasugi T, Takahashi H, Funahashi H, Sato M and Takeyama H: Loss
of PTEN expression is associated with colorectal cancer liver
metastasis and poor patient survival. BMC Gastroenterol. 8:562008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ermoian RP, Furniss CS, Lamborn KR, Basila
D, Berger MS, Gottschalk AR, Nicholas MK, Stokoe D and Haas-Kogan
DA: Dysregulation of PTEN and protein kinase B is associated with
glioma histology and patient survival. Clin Cancer Res.
8:1100–1106. 2002.PubMed/NCBI
|
|
37
|
Mithal P, Allott E, Gerber L, Reid J,
Welbourn W, Tikishvili E, Park J, Younus A, Sangale Z, Lanchbury
JS, et al: PTEN loss in biopsy tissue predicts poor clinical
outcomes in prostate cancer. Int J Urol. 21:1209–1214. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cordes I, Kluth M, Zygis D, Rink M, Chun
F, Eichelberg C, Dahlem R, Fisch M, Höppner W, Wagner W, et al:
PTEN deletions are related to disease progression and unfavourable
prognosis in early bladder cancer. Histopathology. 63:670–677.
2013.PubMed/NCBI
|
|
39
|
Wise HM, Hermida MA and Leslie NR:
Prostate cancer, PI3K, PTEN and prognosis. Clin Sci (Lond).
131:197–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tao J, Xiong J, Li T, Yang Z, Li X, Li K,
Wu H and Wang C: Correlation between protein expression of PTEN in
human pancreatic cancer and the proliferation, infiltration,
metastasis and prognosis. J Huazhong Univ Sci Technolog Med Sci.
26:444–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stambolic V, Suzuki A, de la Pompa JL,
Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM,
Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent
cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kohnoh T, Hashimoto N, Ando A, Sakamoto K,
Miyazaki S, Aoyama D, Kusunose M, Kimura M, Omote N, Imaizumi K, et
al: Hypoxia-induced modulation of PTEN activity and EMT phenotypes
in lung cancers. Cancer Cell Int. 16:332016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nogueira C, Kim KH, Sung H, Paraiso KH,
Dannenberg JH, Bosenberg M, Chin L and Kim M: Cooperative
interactions of PTEN deficiency and RAS activation in melanoma
metastasis. Oncogene. 29:6222–6232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou YJ, Xiong YX, Wu XT, Shi D, Fan W,
Zhou T, Li YC and Huang X: Inactivation of PTEN is associated with
increased angiogenesis and VEGF overexpression in gastric cancer.
World J Gastroenterol. 10:3225–3229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zheng T, Meng X, Wang J, Chen X, Yin D,
Liang Y, Song X, Pan S, Jiang H and Liu L: PTEN- and p53-mediated
apoptosis and cell cycle arrest by FTY720 in gastric cancer cells
and nude mice. J Cell Biochem. 111:218–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang LL, Liu J, Lei S, Zhang J, Zhou W
and Yu HG: PTEN inhibits the invasion and metastasis of gastric
cancer via downregulation of FAK expression. Cell Signal.
26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He RF, Hu ZL and Wen JF: Biological
implication of PTEN gene expression in human gastric cancer and
related molecular mechanisms. Zhonghua Bing Li Xue Za Zhi.
36:324–328. 2007.(In Chinese). PubMed/NCBI
|
